| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 566 | 771 | 161 | 0 | 5.808 | 14.516 | 20.680 | 73.351 |
| Total Income - EUR | - | - | 566 | 771 | 161 | 0 | 5.808 | 14.516 | 20.680 | 73.351 |
| Total Expenses - EUR | - | - | 0 | 42 | 57 | 0 | 53 | 305 | 8.570 | 15.570 |
| Gross Profit/Loss - EUR | - | - | 566 | 729 | 104 | 0 | 5.755 | 14.211 | 12.110 | 57.781 |
| Net Profit/Loss - EUR | - | - | 549 | 717 | 99 | -39 | 5.581 | 12.992 | 11.903 | 55.624 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Hepatomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 610 | 771 | 852 | 10 | 5.687 | 4.464 | 12.592 | 18.121 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 164 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | 446 | 771 | 852 | 10 | 5.687 | 4.464 | 12.592 | 18.121 |
| Shareholders Funds | - | - | 593 | 768 | 852 | 10 | 5.630 | 4.086 | 11.951 | 15.681 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 17 | 3 | 0 | 0 | 57 | 379 | 641 | 2.440 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hepatomed Srl